Evidence map›Paper›PMID 29793736›Full record

Trial reportChest2018

Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial.

Alana M Rojewski, Nichole T Tanner, Lin Dai, James G Ravenel, Mulugeta Gebregziabher, Gerard A Silvestri, Benjamin A Toll

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Chest, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. The Impact of Older Age on Smoking Cessation Outcomes After Standard Advice to Quit.Journal of applied gerontology : the official journal of the Southern Gerontological Society · 2023
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Human mutation · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Comparing the Fagerström Test and Heaviness of Smoking Index in Predicting Smoking Abstinence in Cancer Patients.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Epidemiology of Lung Cancer in Kazakhstan: Trends and Geographic Distribution.Asian Pacific journal of cancer prevention : APJCP · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Alana M RojewskiDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC. Electronic address: rojewski@musc.edu.
Nichole T TannerHealth Equity and Rural Outreach Innovation Center (HEROIC), Ralph H. Johnson VA Medical Center, Charleston, SC; Division of Pulmonary, Critical Care and Sleep Medicine, Medical University of South Carolina, Charleston, SC.
Lin DaiDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC.
James G RavenelHollings Cancer Center, Charleston, SC; Department of Radiology and Radiologic Sciences, Medical University of South Carolina, Charleston, SC.
Mulugeta GebregziabherDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC; Health Equity and Rural Outreach Innovation Center (HEROIC), Ralph H. Johnson VA Medical Center, Charleston, SC.
Gerard A SilvestriDivision of Pulmonary, Critical Care and Sleep Medicine, Medical University of South Carolina, Charleston, SC; Hollings Cancer Center, Charleston, SC.
Benjamin A TollDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC; Hollings Cancer Center, Charleston, SC.
Medical University of South Carolina · USMUSC Hollings Cancer Center · USRalph H. Johnson VA Medical Center · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John J Lemasters · 2009 to 2026
$42.7M
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung CancerP50CA196530 · NCI · YALE UNIVERSITY · PI Harriet M. Kluger · 2015 to 2026
$31.1M
Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening ProgramsR01CA207229 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TOLL, BENJAMIN ANDREW · 2016 to 2022
$3.0M
Tobacco Treatment in the Context of Lung Cancer Screening - Administrative SupplementK07CA214839 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ROJEWSKI, ALANA · 2017 to 2021
$911k
NCI NIH HHS K07 CA214839NCI NIH HHS P30 CA138313NCI NIH HHS P50 CA196530NCI NIH HHS R01 CA207229
6 · The paper itself

Abstract

backgroundIncorporating tobacco treatment within lung cancer screening programs has the potential to influence cessation in high-risk smokers. We aimed to better understand the characteristics of smokers within a screening cohort, correlate those variables with downstream outcomes, and identify predictors of continued smoking.

methodsThis study is a secondary analysis of the National Lung Screening Trial randomized clinical study. Tobacco dependence was evaluated by using the Fagerstrӧm Test for Nicotine Dependence, the Heaviness of Smoking Index, and time to first cigarette (TTFC); descriptive statistics were performed. Clinical outcomes (smoking cessation, lung cancer, and mortality) were assessed with descriptive statistics and χ

resultsPatients with high dependence scores were less likely to quit smoking compared with low dependence smokers (TTFC OR, 0.50 [95% CI, 0.42-0.60]). Indicators of high dependence, as measured according to all three metrics, were associated with worsening clinical outcomes. TTFC showed that patients who smoked within 5 min of waking (indicating higher dependence) had higher rates of lung cancer (2.07% for > 60 min after waking vs 5.92% ≤ 5 min after waking; hazard ratio [HR], 2.56 [95% CI, 1.49-4.41]), all-cause mortality (5.38% for > 60 min vs 11.21% ≤ 5 min; HR, 2.19 [95% CI, 1.55-3.09]), and lung cancer-specific mortality (0.55% for > 60 min vs 2.92% for ≤ 5 min; HR, 4.46 [95% CI, 1.63-12.21]).

conclusionsUsing TTFC, a one-question assessment of tobacco dependence, at the time of lung cancer screening has implications for personalizing tobacco treatment and improving risk assessment.

Indexed as

AgedEarly Detection of CancerFemaleHumansLung NeoplasmsMaleMass ScreeningMiddle AgedPrognosisRadiography, ThoracicRisk AssessmentRisk FactorsSmokingSmoking CessationSouth CarolinaSurvival Ratelung cancernicotine dependencesmokingsmoking cessation

Identifiers

PMID29793736
PMCPMC6045783
OpenAlexW2803554210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.